CUE: Cue Biopharma, Inc. Stock

by  •  • Comments Off on CUE: Cue Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 61.70
Enterprise Value ($M) 34.57
Book Value ($M) 25.37
Book Value / Share 0.40
Price / Book 2.43
NCAV ($M) 17.81
NCAV / Share 0.28
Price / NCAV 3.46

Profitability (mra)
Return on Invested Capital (ROIC) -1.28
Return on Assets (ROA) -0.73
Return on Equity (ROE) -1.20

Liquidity (mrq)
Quick Ratio 2.22
Current Ratio 2.22

Balance Sheet (mrq) ($M)
Current Assets 37.26
Assets 44.81
Liabilities 19.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Slate Path Capital LP 1.40 -61.75
10-07 13G/A Bleichroeder LP 9.99 122.42

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 67,124 193,008 34.78
2025-03-13 32,793 91,059 36.01
2025-03-12 54,942 168,758 32.56
2025-03-11 28,059 107,237 26.17
2025-03-10 58,742 182,985 32.10

(click for more detail)

Similar Companies
CSBR – Champions Oncology, Inc. CSCI – COSCIENS Biopharma Inc.
CTXR – Citius Pharmaceuticals, Inc. CVKD – Cadrenal Therapeutics, Inc.
CYCC – Cyclacel Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io